Regenerative Therapies Library
Every article, presentation, spotlight, and news item we've tagged to Regenerative Therapies.
Showing 193–216 of 310
IgG Glycan Age Predicts Mortality; Plasma Exchange Reverses It
IgG N-glycome patterns independently predict all-cause mortality across 20,405 individuals and respond to intervention, meeting established criteria for a valid aging biomarker. Therapeutic plasma exchange produced the largest reduction in glycan age at 0.4 years per month, positioning glycan structure as both a mechanistic link to chronic inflammation and a measurable target for lifespan extension.
IgG Glycans Reverse Aging Markers via Plasma Exchange
IgG glycan patterns—sugar structures attached to immune antibodies—function as modifiable biological aging markers that predict mortality risk and respond to interventions like therapeutic plasma exchange. Analysis of over 20,000 individuals across 42 studies establishes glycans as measurable indicators of immune aging that shift toward healthier profiles with targeted interventions.
NADMED backs Cleveland Clinic transplant study
Cleveland Clinic's awarded research uses redox biology—specifically NAD and NADH measurement—to assess metabolic viability of donor organs during the ischemic period before transplantation. This work translates longevity science concepts into actionable clinical tools for organ quality assessment and transplant outcomes.
Correction to “Spatial Reorganization of Chromatin Architecture Shapes the Expression Phenotype of Therapy‐Induced Senescent Cells”
This correction addresses a published study on how senescent cells reorganize their chromatin architecture in response to therapeutic stress. Understanding the structural changes in non-dividing cells has direct implications for improving cellular resilience and longevity through better therapeutic design.
Senescent Cell Pathways: Primary vs Secondary Origins
Research distinguishes primary senescent cells (induced by direct damage like radiation) from secondary senescent cells (induced by signals from neighboring senescent cells). This heterogeneity in senescent cell populations has direct implications for understanding aging progression and designing interventions targeting cellular senescence.
Mitochondrial therapy restores metabolic function without appetite
MitoRx's MTRX31 targets mitochondrial dysfunction rather than appetite suppression, achieving significant fat loss while preserving muscle and metabolic function in preclinical models. This metabolic-first approach addresses a fundamental limitation of current obesity drugs: weight loss achieved through caloric restriction often comes with muscle loss and metabolic compromise.
In Vivo Macrophage Reprogramming Expands Regenerative Therapy Access
Resolution Therapeutics is developing an in vivo regenerative macrophage therapy that reprograms immune cells directly within the body using mRNA-carrying lipid nanoparticles, rather than extracting and modifying cells ex vivo. This approach could extend regenerative medicine access to patients with advanced liver disease and chronic inflammatory conditions by eliminating manufacturing complexity.
SIRT6 Gene Therapy Reverses Aging Markers in Living Mammals
Genflow's SLAB trial demonstrated that SIRT6 gene therapy reduced biological age in aging beagles, as measured by methylation clocks, compared to saline controls across multiple treatment modalities. This result advances the translation of senolytic and rejuvenation approaches from cell models to living organisms, establishing feasibility for age-reversal interventions in mammalian aging.
Senescent Factors Suppress Innate Antiviral Immunity in Aged Mice via Two Distinct Mechanisms
Senescent cells accumulate with age and suppress antiviral immunity through four secreted factors—GDF15, IGF1, IL1α, and IL6—via two distinct signaling pathways. Blocking these factors restores innate antiviral defense in aged mice, offering a mechanistic target to improve immune resilience against infection in older adults.
Hepatic Mitochondrial Density Restored Without Appetite Suppression
MitoRx Therapeutics reported preclinical electron microscopy data showing its lead small molecule MTRX31 restored hepatic mitochondrial density in diet-induced obese mice to levels seen in lean controls, while reducing liver lipid droplets and normalizing glycogen handling. The company positions the compound as a non-appetite-suppressing approach to clearing ectopic fat by repairing mitochondrial function rather than restricting intake. If replicated in humans, the approach would target metabolic inflexibility itself, a feature that tracks closely with age-related decline in tissue function.
Mirroring tissue senescence in human biofluids
Researchers have developed a non-invasive urine-based biomarker panel to monitor cellular senescence and track the efficacy of senolytic therapies. This approach enables real-time assessment of senescent cell burden without tissue biopsy, creating a practical pathway for personalized intervention monitoring in aging-related disease.
Tissue telomere coregulators reshape heart disease risk
Tissue-specific genetic analysis identifies coregulatory factors in telomere maintenance that modulate ischemic heart disease risk. This work bridges cellular aging mechanisms and cardiovascular disease susceptibility, revealing that telomere biology operates through tissue-dependent pathways rather than uniform systemic control.
The puzzling duality of mesenchymal stem cells and adipocytes in bone marrow and ageing
Mesenchymal stem cells in bone marrow show contradictory roles in aging—they support bone regeneration but accumulate as fat cells that displace bone-forming capacity. This duality reveals why bone density declines despite maintained stem cell populations, a critical mechanism in skeletal aging.
Mitochondrial repair approach targets muscle loss in aging
Istesso has initiated a Phase 2 trial of leramistat, a mitochondrial complex I modulator designed to restore muscle repair capacity in sarcopenia patients. The therapy represents a shift from symptom management toward regenerative intervention, addressing a condition affecting one in three adults over 60 with no currently approved treatments.
Silencing Growth Hormone Has Strong Effects in Mouse Brains
Suppressing growth hormone signaling in adipose tissue of aged mice preserved cognitive function, reduced neuroinflammation and cellular senescence, and restored neural firing patterns to near-youthful levels. This demonstrates adipose tissue as a peripheral regulator of brain aging independent of systemic growth hormone levels.
Building a ‘Swiss Army Knife’ longevity drug
LinkGevity is developing a small-molecule therapeutic targeting necrosis—uncontrolled cell death—as an upstream driver of multiple age-related diseases. By intervening at this central physiological node, the approach aims to address degenerative change across chronic conditions simultaneously rather than treating diseases individually.
Some Researchers Choose Replacement Over Repair in Aging
Replacement-based interventions—substituting damaged cells, tissues, organs, and physiological systems with biological or synthetic alternatives—are emerging as a pragmatic complement to endogenous repair strategies in aging research. Multiple research organizations are advancing clinical applications ranging from stem cell therapies for structural injuries to bioprinted organs and genetic replacements derived from long-lived species.
The HIF‐1α Pathway Regulates Satellite Cell Fate During Aging Through Histone Lactylation
Pharmacological reactivation of HIF-1α signaling in aged satellite cells restores lactate-driven epigenetic remodeling and shifts cells from senescence toward a regenerative state, with treated cells demonstrating enhanced myogenic capacity and increased ATP production. This identifies a metabolic-epigenetic axis relevant to age-related muscle decline and suggests a therapeutic target for sarcopenia.
Dual gene therapy targets muscle aging
Unlimited Bio has initiated a Phase 1/2a clinical trial combining AAV9-Follistatin and VEGF plasmid gene therapy to address age-related muscle loss and vascular insufficiency. The dual approach targets both muscle growth capacity and the circulatory support system that sustains muscle function—a systems-level intervention designed to address interconnected aspects of aging.
Restoring Lysosomal Clearance Targets Parkinson's Root Cause
Researchers identified a protein mechanism that restores lysosomal clearance of alpha-synuclein, the pathogenic protein in Parkinson's disease. This addresses a fundamental aging problem: the cell's declining ability to eliminate misfolded proteins, which accelerates neurodegeneration when these proteins accumulate and further impair cellular cleanup systems.
AI regenerative medicine targets skin recovery
ROKIT Healthcare presented two-year clinical data on AI-driven bioprinting for skin cancer reconstruction using patients' own fat cells, demonstrating 0% recurrence, restored function and sensation, and minimal scarring. This represents a shift in how medicine approaches post-surgical recovery—from wound closure alone to restoration of tissue architecture and sensory integrity.
Muscle preservation emerges as critical GLP-1 treatment frontier
NorthStrive Biosciences has filed patent applications for two distinct muscle-preservation technologies—a peptide (EL-22) and an engineered microorganism platform (EL-32)—designed to mitigate lean mass loss during GLP-1 and multi-hormone weight-loss treatment. This represents a shift in obesity medicine from maximizing weight loss alone to preserving metabolic and structural integrity during pharmacological intervention.
Gene therapy reprograms cartilage cells without grafting
FibroBiologics obtained European patent protection for a gene therapy approach that instructs fibroblast cells to differentiate into cartilage-producing cells using Sox9 and related genetic sequences. The technology addresses cartilage degradation through cellular reprogramming rather than surgical grafting, with potential application across orthopedic and spinal conditions.
3D Culture Reverses Stem Cell Aging Via Mitochondrial Protection
Three-dimensional culture systems reverse cellular aging in limbal niche cells through activation of FOSL1, a transcription factor that preserves mitochondrial function and reduces oxidative stress. This finding addresses a critical barrier to clinical stem cell therapies for corneal regeneration, where conventional culture methods accelerate cellular aging during expansion.